Check out the companies making headlines before the bell. Chemours — The chemical company added about 3% after UBS upgraded the company from buy to neutral, saying the stock could outperform as refrigerants see favorable demand and price drivers heading into next year. Nvidia — Shares rose more than 1% after KeyBanc hiked its price target on the chipmaker to $180, implying upside of more than 40% from Monday’s close. “Despite the impending launch of Blackwell in 2H24, we are not seeing any signs of a demand pause as demand for H100 remains robust,” KeyBanc said. BP — The oil and gas giant’s U.S.-listed shares fell more than 4% after the company warned it expects to report an impairment of up to $2 billion. BP also sees weak margins from its refining business . Tempus AI — Shares popped nearly 4% after several Wall Street banks initiated coverage of the health care diagnostics company with buy or overweight ratings. Tempus AI, which uses artificial intelligence to interpret medical tests, debuted on the Nasdaq in June. Intel — The chipmaker rose 2.7% in early morning trading, continuing its come back this week. Week-to-date, shares are up roughly 6.1%. Helen of Troy — Shares of the Hydro Flask and Oxo parent fell more than 25% on the back of a big earnings miss. The company earned 99 cents per share, excluding items. Analysts polled by FactSet expected a profit of $1.59 per share. Quarterly revenue guidance was also below estimates. — CNBC’s Fred Imbert and Michelle Fox Theobald contributed reporting.
EMEA Tribune is not involved in this news article, it is taken from our partners and or from the News Agencies. Copyright and Credit go to the News Agencies, email news@emeatribune.com Follow our WhatsApp verified Channel
